Immutep (Immutep) Cash Flow from Operations

: $-26.71 Mil (TTM As of Dec. 2023)

View and export this data going back to 1988. Start your Free Trial

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Dec. 2023, Immutep's Cash Receipts from Operating Activities was $2.55 Mil. Its Cash Payments was $-6.93 Mil. Its Dividends Paid was $0.00 Mil. Its Dividends Received was $0.00 Mil. Its Interest Paid was $-0.01 Mil. Its Interest Received was $0.64 Mil. Its Taxes Refund Paid was $0.00 Mil. And its Cash Flow from Others was $-0.00 Mil. In all, Immutep's Cash Flow from Operations for the three months ended in Dec. 2023 was $-3.75 Mil.

Immutep Cash Flow from Operations Historical Data

The historical data trend for Immutep's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immutep Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Cash Flow from Operations

Get a 7-Day Free Trial

-10.62

-7.48

-13.49

-21.24

-23.73

Immutep Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash Flow from Operations	Get a 7-Day Free Trial															-3.76	-9.46	-5.25	-8.26	-3.75

Immutep Cash Flow from Operations Calculation

Immutep's Cash Flow from Operations for the fiscal year that ended in Jun. 2023 is calculated as:

	Cash Flow from Operations		(A: Jun. 2023 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	2.509	+	-26.84	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	-0.014	+	0.616	+	0	+	0
=	-23.73

Immutep's Cash Flow from Operations for the quarter that ended in Dec. 2023 is:

	Cash Flow from Operations		(Q: Dec. 2023 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	2.552	+	-6.928	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	-0.005	+	0.637	+	0	+	-0.0010000000000008
=	-3.75

Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.71 Mil.

Immutep (NAS:IMMP) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Immutep's cash receipts from operating activities for the three months ended in Dec. 2023 was $2.55 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Immutep's cash payments for the three months ended in Dec. 2023 was $-6.93 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Immutep's cash payments for the three months ended in Dec. 2023 was $0.00 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Immutep's cash payments for the three months ended in Dec. 2023 was $0.00 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Immutep's cash payments for the three months ended in Dec. 2023 was $-0.01 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Immutep's cash payments for the three months ended in Dec. 2023 was $0.64 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Immutep's cash payments for the three months ended in Dec. 2023 was $0.00 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Immutep's cash flow from others for the three months ended in Dec. 2023 was $-0.00 Mil.

Immutep Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Immutep's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Immutep (Immutep) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immutep Ltd (NAS:IMMP) » Definitions » Cash Flow from Operations

Comparable Companies

Traded in Other Exchanges

PRRUF:USA YP1B:Germany IMM:Australia

Address

264 George Street, Level 33, Australia Square, Sydney, NSW, AUS, 2000

Website

https://www.immutep.com

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trails, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia and derives the majority of the revenue from the sale of the products.